Leadership/Faculty/Staff
Research Programs
Clinical Trials/Studies
Referral Information
Travel/Local Information
Support Programs/Services
Educational Programs
The Power of Giving
Make a Donation
Online Shopping
Fundraising Events
Faces of Hope
Journey of Hope
Voices of Hope
Family Scrapbook
Mission and History
Careers
Board of Advisors
Community Partners
In the News
|
|
 Photo courtesy of Duke University Medical Center
|
Henry S. Friedman, MD
—James B. Powell, Jr., Professor of Neuro-Oncology —Professor of Pediatrics —Associate Professor of Surgery and Medicine —Assistant Professor of Pathology —Deputy Director, The Preston Robert Tisch Brain Tumor Center at Duke Duke University Medical Center 047 Baker House, Trent Drive DUMC Box 3624 Durham, NC 27710 Tel: (919) 684-5301 Fax: (919) 681-1697 Email: fried003@mc.duke.edu |
“We know that a brain tumor is unlike any other disease. We take an aggressive team approach to find answers and provide hope. We play to win. We want survivors.” |
|
Henry S. Friedman, MD, is an internationally recognized neuro-oncologist with a career-long interest in the treatment of children and adults with brain and spinal cord tumors. He has written hundreds of articles on both the clinical and laboratory investigation of these neoplasms.
Dr. Friedman's CV | Publications | Chapters | Abstracts | |
|
Recent Publications:
Younis IR,Malone S,Friedman HS,Schaaf LJ,Petros WP. Enterohepatic recirculation model of irinotecan (CPT-11) and metabolite pharmacokinetics in patients with glioma.,May 22,2008, (-) - Cancer chemotherapy and pharmacology Abstract [More ...]
Bacolod MD,Lin SM,Johnson SP,Bullock NS,Colvin M,Bigner DD,Friedman HS. The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide.,May 01,2008, (172-9) - Current cancer drug targets Abstract [More ...]
Everson RG,Graner MW,Gromeier M,Vredenburgh JJ,Desjardins A,Reardon DA,Friedman HS,Friedman AH,Bigner DD,Sampson JH. Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.,May 01,2008, (717-32) - Expert review of anticancer therapy Abstract [More ...]
Sampson JH,Akabani G,Archer GE,Berger MS,Coleman RE,Friedman AH,Friedman HS,Greer K,Herndon Ii JE,Kunwar S,McLendon RE,Paolino A,Petry NA,Provenzale JM,Reardon DA,Wong TZ,Zalutsky MR,Pastan I,Bigner DD. Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.,Apr 10,2008, (-) - Neuro-oncology Abstract [More ...]
Reardon DA,Desjardins A,Vredenburgh JJ,Sathornsumetee S,Rich JN,Quinn JA,Lagattuta TF,Egorin MJ,Gururangan S,McLendon R,Herndon Ii JE,Friedman AH,Salvado AJ,Friedman HS. Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: Phase 1 trial in adults with malignant glioma.,Mar 21,2008, (-) - Neuro-oncology Abstract [More ...]
Reardon DA,Zalutsky MR,Akabani G,Coleman RE,Friedman AH,Herndon JE 2nd,McLendon RE,Pegram CN,Quinn JA,Rich JN,Vredenburgh JJ,Desjardins A,Guruangan S,Boulton S,Raynor RH,Dowell JM,Wong TZ,Zhao XG,Friedman HS,Bigner DD. A pilot study: 131I-Antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost.,Feb 20,2008, (-) - Neuro-oncology Abstract [More ...]
Gururangan S,Turner CD,Stewart CF,O'Shaughnessy M,Kocak M,Poussaint TY,Phillips PC,Goldman S,Packer R,Pollack IF,Blaney SM,Karsten V,Gerson SL,Boyett JM,Friedman HS,Kun LE. Phase I Trial of VNP40101M (Cloretazine) in Children with Recurrent Brain Tumors: A Pediatric Brain Tumor Consortium Study.,Feb 15,2008, (1124-30) - Clinical cancer research : an official journal of the American Association for Cancer Research Abstract [More ...]
Sathornsumetee S,Cao Y,Marcello JE,Herndon JE 2nd,McLendon RE,Desjardins A,Friedman HS,Dewhirst MW,Vredenburgh JJ,Rich JN. Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan.,Jan 10,2008, (271-8) - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Abstract [More ...]
Zalutsky MR,Reardon DA,Akabani G,Coleman RE,Friedman AH,Friedman HS,McLendon RE,Wong TZ,Bigner DD. Clinical Experience with {alpha}-Particle Emitting 211At: Treatment of Recurrent Brain Tumor Patients with 211At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6.,Dec 12,2007, (-) - Journal of nuclear medicine : official publication, Society of Nuclear Medicine Abstract [More ...]
Broniscer A,Gururangan S,MacDonald TJ,Goldman S,Packer RJ,Stewart CF,Wallace D,Danks MK,Friedman HS,Poussaint TY,Kun LE,Boyett JM,Gajjar A. Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report.,Nov 15,2007, (6712-8) - Clinical cancer research : an official journal of the American Association for Cancer Research Abstract [More ...] |
NOTE: For more publications on this researcher, please visit Pubmed - A service of the National Library of Medicine and the National Institutes of Health.
Back to top
|
|